A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SAB / Staphylococcus aureus bacteremia

[Related PubMed/MEDLINE]
Total Number of Papers: 240
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SAB  (>> Co-occurring Abbreviation)
Long Form:   Staphylococcus aureus bacteremia
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A retrospective study (2001-2017) of acute and chronic morbidity and mortality associated with Staphylococcus aureus bacteraemia in a tertiary neonatal intensive care unit. ---
2019 Age-Dependent Increase in Incidence of Staphylococcus aureus Bacteremia, Denmark, 2008-2015. ---
2019 Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study. CCs, MLST
2019 Clinical Practice Variation Among Adult Infectious Diseases Physicians in the Management of Staphylococcus aureus Bacteremia. ---
2019 Comparison of knowledge to antimicrobial stewardship institution policies targeting Staphylococcus aureus bacteremia and candidemia between medical doctors and pharmacists in an academic teaching hospital in Japan. ASPs, CIs, MDs, ORs
2019 Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes. ---
2019 Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial. ---
2019 Impact of an Unsolicited, Standardized Form-Based Antimicrobial Stewardship Intervention to Improve Guideline Adherence in the Management of Staphylococcus aureus Bacteremia. ASPs, PAF
2019 Increased risk of Staphylococcus aureus bacteremia in hemodialysis-A nationwide study. CVC, RR
10  2019 Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia. ---
11  2019 Risk Factors and Outcomes Associated With Hospital-Onset Peripheral Intravenous Catheter-Associated Staphylococcus aureus Bacteremia. CI, HO, OR, ORs, PVCs
12  2019 Utility of qSOFA score in identifying patients at risk for poor outcome in Staphylococcus aureus bacteremia. PBS, qSOFA, SIRS
13  2019 [Staphylococcus aureus Bacteraemia - an Interdisciplinary Challenge]. MRSA
14  2018 18F-FDG-PET/CT-guided treatment duration in patients with high-risk Staphylococcus aureus bacteremia: a proof of principle. ---
15  2018 A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia. ASP, CI, ID, NAM
16  2018 Are we missing the Staphylococcus aureus bacteraemia forest for the MRSA trees? ---
17  2018 Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2016. AGAR, ASSOP, MRSA, MSSA
18  2018 Automatic notification and infectious diseases consultation for patients with Staphylococcus aureus bacteremia. ID, QCIs
19  2018 Clinical variation in the use of echocardiography in Staphylococcus aureus bacteraemia: a multi-centre cohort study. ---
20  2018 Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study. ISC
21  2018 Early oral switch to linezolid for low-risk patients with Staphylococcus aureus bloodstream infections: a propensity-matched cohort study. SPT
22  2018 Early use of peripherally inserted central catheters is safe in Staphylococcus aureus bacteraemia. PICC
23  2018 Echocardiography has low utility in cancer patients with Staphylococcus aureus bacteraemia: findings from a retrospective study. IE, TOE, TTE
24  2018 Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease. CCWI, MRSAB
25  2018 Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia. ---
26  2018 Human genetic variation in GLS2 is associated with development of complicated Staphylococcus aureus bacteremia. CC, WES
27  2018 Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study. ASP, MRSA, OCS
28  2018 Impact of antimicrobial treatment duration on outcome of Staphylococcus aureus bacteraemia: a cohort study. LW, SOFA, SS
29  2018 Implementing a hospital-wide protocol for Staphylococcus aureus bacteremia. TEE
30  2018 Increased overall survival after introduction of structured bedside consultation in Staphylococcus aureus bacteraemia. SBC, TEE
31  2018 Infection characteristics and treatment of Staphylococcus aureus bacteraemia at a tertiary children's hospital. MRSA
32  2018 Long-term Staphylococcus aureus decolonization in patients on home parenteral nutrition: study protocol for a randomized multicenter trial. CS, HPN, SD
33  2018 Methicillin-sensitive Staphylococcus aureus bacteremia in aged patients: the importance of formal infectious specialist consultation. ISC, MS
34  2018 Molecular Epidemiology of Staphylococcus aureus Bacteremia: Association of Molecular Factors With the Source of Infection. CA, CC, HA, MRSA
35  2018 Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia. ---
36  2018 Pharmacist-driven initiative for management of Staphylococcus aureus bacteremia using a clinical decision support system. CDSS, ID
37  2018 Practice Patterns of Providers for the Management of Staphylococcus aureus Bacteremia in Children: Results of an Emerging Infections Network Survey. ---
38  2018 Predictors of Mortality with Staphylococcus aureus Bacteremia in Elderly Adults. MRSA
39  2018 Predictors of one-year all-cause mortality and infection-related mortality in patients with Staphylococcus aureus bacteraemia. ---
40  2018 Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a review. IE, PWID
41  2018 Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study. BSI
42  2018 The management and outcomes of Staphylococcus aureus bacteraemia at a South African referral hospital: A prospective observational study. CI, MRSA, OR
43  2018 The updated Charlson comorbidity index is a useful predictor of mortality in patients with Staphylococcus aureus bacteraemia. cCCI, uCCI
44  2018 Trends in incidence and resistance patterns of Staphylococcus aureus bacteremia. CA, HA, MRSA, PSSA
45  2018 What risk of endocarditis is low enough to justify the omission of transoesophageal echocardiography in Staphylococcus aureus bacteraemia? A narrative review. TOE
46  2017 18F-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality. ---
47  2017 An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia. ASPs, ID
48  2017 Association Between Staphylococcus aureus Bacteremia and Hospital Mortality in Hemodialysis Patients With Bloodstream Infection: A Multicenter Cohort From Japanese Tertiary Care Centers. AVF, BSI
49  2017 Clinical predictors and clinical prediction rules to estimate initial patient risk for infective endocarditis in Staphylococcus aureus bacteraemia: a systematic review and meta-analysis. IE, NLR, PLR, TEE
50  2017 Clinical presentation, management and outcomes of Staph aureus bacteremia (SAB) in older adults. TEE
51  2017 Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia-a post hoc analysis in 964 prospectively evaluated patients. ---
52  2017 Comparative Sensitivity of Transthoracic and Transesophageal Echocardiography in Diagnosis of Infective Endocarditis Among Veterans With Staphylococcus aureus Bacteremia. IE, TEE, TTE
53  2017 Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis. QCIs
54  2017 Diabetes increases the risk of disease and death due to Staphylococcus aureus bacteremia. A matched case-control and cohort study. CI, HR, OR
55  2017 Epidemiology and hospital readmission associated with complications of Staphylococcus aureus bacteremia in pediatrics over a 25-year period. MRSA, OR
56  2017 Evaluating genetic susceptibility to Staphylococcus aureus bacteremia in African Americans using admixture mapping. AA, AM, SNP
57  2017 Expression of HLA-DRA and CD74 mRNA in whole blood during the course of complicated and uncomplicated Staphylococcus aureus bacteremia. MHC
58  2017 Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study. aHR, HRs
59  2017 Guideline compliance and clinical outcomes among patients with Staphylococcus aureus bacteremia with infectious diseases consultation in addition to antimicrobial stewardship-directed review. ASP, IDC
60  2017 Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia. IL-10
61  2017 Paediatric Staphylococcus aureus bacteraemia: A single-centre retrospective cohort. CHW, IE
62  2017 Persistent bacteraemia caused by Staphylococcus aureus in the gall bladder. ---
63  2017 Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia. ---
64  2017 Prognostic impact of hyperglycemia at onset of methicillin-sensitive Staphylococcus aureus bacteraemia. MS-SAB
65  2017 Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia. Vt
66  2017 Risk assessment for infected endocarditis in Staphylococcus aureus bacteremia patients: When is transesophageal echocardiography needed? IVDA, TEE
67  2017 Staphylococcus aureus bacteremia in immunosuppressed patients: a multicenter, retrospective cohort study. CI, IC, IS, SHR
68  2017 Staphylococcus aureus bacteremia in patients with rheumatoid arthritis - Data from the prospective INSTINCT cohort. OAI, RA
69  2017 Study on the utility of a statewide counselling programme for improving mortality outcomes of patients with Staphylococcus aureus bacteraemia in Thuringia (SUPPORT): a study protocol of a cluster-randomised crossover trial. IDC
70  2017 Telavancin in the Treatment of Concurrent Staphylococcus aureus Bacteremia: A Retrospective Analysis of ATLAS and ATTAIN Studies. AEs, cSSSI, HABP/VABP, TLV, VAN
71  2017 The associations between socioeconomic status and risk of Staphylococcus aureus bacteremia and subsequent endocarditis - a Danish nationwide cohort study. CI, IRRs, SES
72  2017 The Risk of Cardiac Device-Related Infection in Bacteremic Patients Is Species Specific: Results of a 12-Year Prospective Cohort. AICDs, CD, CDRI, CI, GNB, LVADs, OR, PHVs, PPMs
73  2017 The Scottish enhanced Staphylococcus aureus bacteraemia surveillance programme: the first 18 months of data in children. NHS
74  2017 The Scottish enhanced Staphylococcus aureus bacteraemia surveillance programme: the first 18months of data in adults. ---
75  2017 Thrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia. HR, MS-SAB
76  2017 Time trends in Staphylococcus aureus bacteremia, 1988-2010, in a tertiary center with high methicillin resistance rates. MRSA
77  2016 Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014. ASSOP, CA, MRSA
78  2016 Chronic heart failure and mortality in patients with community-acquired Staphylococcus aureus bacteremia: a population-based cohort study. aMRR, CA-SAB, CHF, MRRs
79  2016 Diabetes and risk of community-acquired Staphylococcus aureus bacteremia: a population-based case-control study. CA, CI, ORs
80  2016 Enhanced surveillance of Staphylococcus aureus bacteraemia to identify targets for infection prevention. MRSA
81  2016 Epidemiology and Mortality of Staphylococcus aureus Bacteremia in Australian and New Zealand Children. MRSA, MSSA
82  2016 Factors associated with 12week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study. MSSA
83  2016 Fatal endocarditis with methicilin-sensible Staphylococcus aureus and major complications: rhabdomyolysis, pericarditis, and intracerebral hematoma: A case report and review of the literature. CA-MSSA, SA, TSST
84  2016 Impact of Infectious Diseases Consultation on Clinical Outcomes of Patients with Staphylococcus aureus Bacteremia in a Community Health System. IDC
85  2016 Incidence and Risk Factors of Ocular Infection Caused by Staphylococcus aureus Bacteremia. AOR, CI
86  2016 Infectious disease consultation for Staphylococcus aureus bacteremia - A systematic review and meta-analysis. IDC, RR
87  2016 Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany. ID
88  2016 Long-term mortality and causes of death associated with Staphylococcus aureus bacteremia. A matched cohort study. ---
89  2016 Outcome of Community-Acquired Staphylococcus aureus Bacteraemia in Patients with Diabetes: A Historical Population-Based Cohort Study. aMRR, CI, MRRs
90  2016 Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia. CI, RR
91  2016 Peripheral Intravenous Catheter Placement Is an Underrecognized Source of Staphylococcus aureus Bloodstream Infection. PIVs
92  2016 Polymicrobial Staphylococcus aureus bacteremia: Frequency, distinguishing characteristics and outcome. HAP, IVC
93  2016 Predictive Value of C-Reactive Protein (CRP) in Identifying Fatal Outcome and Deep Infections in Staphylococcus aureus Bacteremia. CRP, HR, OR, ROC, WBC
94  2016 Reduction in Staphylococcus aureus bacteraemia rates in patients receiving haemodialysis following alteration of skin antisepsis procedures. AVF, CVC
95  2016 Risk factors for long-term mortality of Staphylococcus aureus bacteremia. ---
96  2016 Should all adjunctive corticosteroid therapy be avoided in the management of hemodynamically stabile Staphylococcus aureus bacteremia? ---
97  2016 Staphylococcus aureus bacteraemia associated with injected new psychoactive substances. NPS
98  2016 The Epidemiology of Staphylococcus aureus and Panton-Valentine Leucocidin (pvl) in Central Australia, 2006-2010. PVL, SNP
99  2016 The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. ---
100  2016 Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia. CI, HRs